In contrast, increase tumor densities of Tregs, measured by surface markers CD4 and CD25 plus intracellular FoxP3, as compared to TM40D control (Figure 2E and F), suggestive of a shift of the Treg population from the circulation to the primary tumor. This evidence concerns the gene CD4 and neoplasm.